Skip to content

Clinical trials

Phase 2 Hereditary Sensory and Autonomic Neuropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hereditary Sensory and Autonomic Neuropathies Phase: Phase 2 Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20091
20102
20113
20122
20131
20162
20172
20184
20193
20206
20214
20223
20232
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated10
Active, not recruiting5
Recruiting5
Unknown status2
Withdrawn1
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
Incyte Corporation3
Actuate Therapeutics Inc.2
EMD Serono Research & Development Institute, Inc.2
NYU Langone Health2
Novartis Pharmaceuticals2
Restorbio Inc.2
Aadi Bioscience, Inc.1
Alejandra Guillermina Miranda Diaz1
AllRock Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hereditary Sensory and Autonomic Neuropathies44
Neoplasm Metastasis5
Breast Neoplasms4
Colorectal Neoplasms3
Neoplasms3
COVID-192
Endometrial Neoplasms2
Lung Neoplasms2
Lymphoma, Non-Hodgkin2
Melanoma2

Trials

Showing 76 to 44 of 44. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.